Nanologica AB (publ) (STO:NICA)
Sweden
· Delayed Price · Currency is SEK 1.065
+0.020 (1.91%)
Jun 5, 2025, 4:02 PM CET
Nanologica AB Revenue
Nanologica AB had revenue of 10.75M SEK in the quarter ending March 31, 2025, with 113.44% growth. This brings the company's revenue in the last twelve months to 20.25M, up 154.68% year-over-year. In the year 2024, Nanologica AB had annual revenue of 14.54M with 211.17% growth.
Revenue (ttm)
20.25M
Revenue Growth
+154.68%
P/S Ratio
4.65
Revenue / Employee
1.27M
Employees
16
Market Cap
94.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.54M | 9.87M | 211.17% |
| Dec 31, 2023 | 4.67M | -1.16M | -19.92% |
| Dec 31, 2022 | 5.83M | -8.91M | -60.43% |
| Dec 31, 2021 | 14.75M | -3.59M | -19.58% |
| Dec 31, 2020 | 18.34M | 6.12M | 50.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |